H.R. 5668: MODERN Labeling Act of 2020

CBO Score


Date of Report

Thu October 29th, 2020

Legislation Details

116th Congress

To amend the Federal Food, Drug, and Cosmetic Act to modernize the labeling of certain generic drugs, and for other purposes.

Sponsor: Rep. Doris Matsui — D — CA

Allows the Secretary of Health and Human Services to require label updates for certain generic drugs once the reference drug’s patents and exclusivities expire, new information is available, and the Secretary determines that the public health would benefit from the updated label. Under current law, labels on generic drugs must match those of their corresponding reference brand drug. The bill also would require the Secretary to report to the Congress every four years on the number and types of such determinations made and on the number of times manufacturers disagreed with those determinations.

View the full vote history of this bill on GovTrack.us.

As a registered user, you receive personalized updates to your inbox or dashboard when elected officials vote to spend more of your money. Choose to receive updates daily, weekly, monthly, or as they happen.


Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

+ + HIGH LOW +
+ + HIGH LOW +